RECENT PLACEMENT

Occam Places Ryan Kelly as Chief Communications Officer at Recursion

Occam Places Ryan Kelly as Chief Communications Officer at Recursion

In April 2022, Occam Global placed Ryan Kelly as Chief Communications Officer of Recursion Pharmaceuticals (RXRX), a clinical-stage biotechnology company industrializing drug discovery by decoding biology. Ryan will be responsible for external and internal communications. Mr. Kelly previously served as Vice President, Global Marketing and Communications at Virgin Hyperloop where he supported commercializing the company’s technology through global strategic communication campaigns.


Read more about Occam's work with Recursion in our case study.

Recent Placements

  1. Geoff McDonough as CEO of Generation Bio
  2. Brian Krex as General Counsel for Public Biopharma KalVista Pharmaceuticals
  3. Andrew Farnum Gates Foundation Leader as CEO at Variant Bio
  4. Emile Nuwaysir as CEO of Ensoma
  5. Emily Conley as CEO of FederationBio
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.